Xeomin

The Food and Drug Administration (FDA) has approved Xeomin for for temporary improvement of moderate to severe glabellar lines (frown lines).  Under the brand name Bocouture, Xeomin is already approved in 14 countries including Germany, France, the United Kingdom, Italy and Spain.  It was FDA-approved in 2010 for the treatment of cervical dystonia and blepharospasm.

What is different about Xeomin vs. Botox & Dysport?

  1. Xeomin does not require refrigeration.
  2. Xeomin contains no additives.  It only contains botulinum toxin type A.

What complications may occur with Xeomin?

  • Xeomin, like other botulinum products, carries the risk of spreading beyond the injection site.  Life-threatening swallowing and breathing problems may result.
  • Bleeding and bruising at the injection site
  • Allergic reactions such as itching, swelling or shortness of breath.

Possible Xeomin side effects when this neurotoxin is used to treat cervical dystonia may include:

  • Neck pain
  • Muscle weakness
  • Injection site pain
  • Musculoskeletal pain.

Xeomin side effects when used to treat blepharospasm may include:

  • Eyelid sagging (ptosis)
  • Dry eye
  • Dry mouth
  • Diarrhea
  • Headache
  • Visual impairment
  • Shortness of breath (dyspnea)
  • Upper respiratory infections.

Where can I find more information about Xeomin?

If you are interested in Xeomin injections you should contact your dermatologist and set up an appointment to discuss your options.  Before undergoing and procedure it is highly recommended and urged that you know all the risks involved.

www.fda.gov

Read: HealthNewsDigest.com Article
Read: FacialPlasticSurgery.net Article
Read: DermatologyTimes Article
Read: Xeomin Facts & Xeomin Safety  

Published on 07/27/2011 | Last updated on 12/20/2016